Treatment of End-of-Dose Wearing-Off in Parkinson’s Disease: Stalevo® (Levodopa/Carbidopa/Entacapone) and Levodopa/DDCI Given in Combination with Comtess®/Comtan® (Entacapone) Provide Equivalent Improvements in Symptom Control Superior to That of Traditional Levodopa/DDCI Treatment

Citation Download

Brooks DJ, Agid Y, Eggert K, Widner H, Østergaard K, Holopainen A:
Treatment of End-of-Dose Wearing-Off in Parkinson's Disease: Stalevo^® (Levodopa/Carbidopa/Entacapone) and Levodopa/DDCI Given in Combination with Comtess^®/Comtan^® (Entacapone) Provide Equivalent Improvements in Symptom Control Superior to That of Traditional Levodopa/DDCI Treatment.
Eur Neurol 2005;53:197-202 (DOI: 10.1159/000086479)

Download:

As text file

Using Citation Manager Software
(EndNote / Reference Manager / ProCite)

Purchase Citation Manager Software:

EndNote

Back

Search in this issue

This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.